Cribriform adenocarcinoma of the minor salivary glands: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
18 Apr 2023
Historique:
received: 30 01 2023
accepted: 06 03 2023
medline: 19 4 2023
entrez: 18 4 2023
pubmed: 19 4 2023
Statut: epublish

Résumé

Polymorphous adenocarcinoma is the third most common malignant salivary gland tumor. Within polymorphous adenocarcinoma, cribriform adenocarcinoma of salivary glands is a rare subtype and resembles papillary thyroid carcinoma histopathologically. Diagnostically, cribriform adenocarcinoma of salivary glands is challenging for pathologists and surgeons alike as initial presentation and cytologic nuclear features can be easily confused with papillary thyroid carcinoma arising from a thyroglossal duct remnant or lingual thyroid. A healthy 64-year-old Caucasian woman presented to a community otolaryngologist with a 4-year history of progressive postnasal drip, globus sensation, and eventual dysphonia. Flexible fiberoptic laryngoscopy showed a large, smooth, vallecular lesion filling the oropharynx. Computed tomography imaging of the neck showed a rounded heterogeneous mass centered within the right aspect of the oropharynx measuring 4.2 × 4.4 × 4.5 cm. Fine needle aspiration biopsy was suspicious for papillary carcinoma due to microscopic findings of malignant cells, nuclear grooves, and a powdery chromatin pattern. In the operating room, the tumor was resected en bloc using a lateral pharyngotomy approach with partial resection of the right lateral hyoid. A limited cervical lymphadenectomy was performed to facilitate the lateral pharyngotomy approach and two out of three lymph nodes demonstrated regional metastatic disease. Nuclear grooves, nuclear membrane notching, and occasional intranuclear pseudoinclusions were identified, which are overlapping histopathological characteristics of papillary thyroid carcinoma and cribriform adenocarcinoma of salivary glands. It was negative for thyroglobulin and thyroid transcription factor-1, which was in keeping with cribriform adenocarcinoma of salivary glands rather than papillary thyroid carcinoma. It is difficult to distinguish cribriform adenocarcinoma of salivary glands from papillary thyroid carcinoma solely by cytology, and the distinct characteristics of regional lymph node metastasis coupled with nuanced histologic differences should be emphasized in the evaluation of patients presenting with neck lymphadenopathy and an unknown primary or tongue mass. If sufficient fine needle aspiration biopsy material is available, thyroid transcription factor-1, thyroglobulin, or molecular testing may prove useful in differentiating cribriform adenocarcinoma of salivary glands from papillary thyroid carcinoma. A misdiagnosis of papillary thyroid carcinoma may lead to inappropriate treatment including unnecessary thyroidectomy. Therefore, it is critical for both pathologists and surgeons to be aware of this uncommon entity to avoid misdiagnosis and subsequent mismanagement.

Sections du résumé

BACKGROUND BACKGROUND
Polymorphous adenocarcinoma is the third most common malignant salivary gland tumor. Within polymorphous adenocarcinoma, cribriform adenocarcinoma of salivary glands is a rare subtype and resembles papillary thyroid carcinoma histopathologically. Diagnostically, cribriform adenocarcinoma of salivary glands is challenging for pathologists and surgeons alike as initial presentation and cytologic nuclear features can be easily confused with papillary thyroid carcinoma arising from a thyroglossal duct remnant or lingual thyroid.
CASE PRESENTATION METHODS
A healthy 64-year-old Caucasian woman presented to a community otolaryngologist with a 4-year history of progressive postnasal drip, globus sensation, and eventual dysphonia. Flexible fiberoptic laryngoscopy showed a large, smooth, vallecular lesion filling the oropharynx. Computed tomography imaging of the neck showed a rounded heterogeneous mass centered within the right aspect of the oropharynx measuring 4.2 × 4.4 × 4.5 cm. Fine needle aspiration biopsy was suspicious for papillary carcinoma due to microscopic findings of malignant cells, nuclear grooves, and a powdery chromatin pattern. In the operating room, the tumor was resected en bloc using a lateral pharyngotomy approach with partial resection of the right lateral hyoid. A limited cervical lymphadenectomy was performed to facilitate the lateral pharyngotomy approach and two out of three lymph nodes demonstrated regional metastatic disease. Nuclear grooves, nuclear membrane notching, and occasional intranuclear pseudoinclusions were identified, which are overlapping histopathological characteristics of papillary thyroid carcinoma and cribriform adenocarcinoma of salivary glands. It was negative for thyroglobulin and thyroid transcription factor-1, which was in keeping with cribriform adenocarcinoma of salivary glands rather than papillary thyroid carcinoma.
CONCLUSION CONCLUSIONS
It is difficult to distinguish cribriform adenocarcinoma of salivary glands from papillary thyroid carcinoma solely by cytology, and the distinct characteristics of regional lymph node metastasis coupled with nuanced histologic differences should be emphasized in the evaluation of patients presenting with neck lymphadenopathy and an unknown primary or tongue mass. If sufficient fine needle aspiration biopsy material is available, thyroid transcription factor-1, thyroglobulin, or molecular testing may prove useful in differentiating cribriform adenocarcinoma of salivary glands from papillary thyroid carcinoma. A misdiagnosis of papillary thyroid carcinoma may lead to inappropriate treatment including unnecessary thyroidectomy. Therefore, it is critical for both pathologists and surgeons to be aware of this uncommon entity to avoid misdiagnosis and subsequent mismanagement.

Identifiants

pubmed: 37069616
doi: 10.1186/s13256-023-03875-4
pii: 10.1186/s13256-023-03875-4
pmc: PMC10110342
doi:

Substances chimiques

Thyroglobulin 9010-34-8
Transcription Factors 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

142

Informations de copyright

© 2023. The Author(s).

Références

Mod Pathol. 2017 Jan;30(s1):S27-S43
pubmed: 28060365
Diagn Cytopathol. 2014 Dec;42(12):1085-90
pubmed: 24550144
Am J Surg Pathol. 2011 Aug;35(8):1168-76
pubmed: 21716087
Oncol Lett. 2011 Jan;2(1):135-138
pubmed: 22870142
Front Endocrinol (Lausanne). 2018 Sep 25;9:555
pubmed: 30337905
Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1681-1695
pubmed: 29761209
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Pol J Pathol. 2011 Sep;62(3):168-71
pubmed: 22102075
Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Apr;133(4):e91-e95
pubmed: 34753697
Ear Nose Throat J. 2004 Jan;83(1):62-4
pubmed: 14986761
Virchows Arch. 2012 Nov;461(5):531-40
pubmed: 23052371
Head Neck Pathol. 2013 Jul;7 Suppl 1:S3-11
pubmed: 23821209
Histopathology. 1999 Dec;35(6):495-501
pubmed: 10583573
Am J Surg Pathol. 2016 Nov;40(11):1526-1537
pubmed: 27454943
Diagn Cytopathol. 2017 May;45(5):468-471
pubmed: 28205384

Auteurs

Tanya Chen (T)

Department of Otolaryngology - Head & Neck Surgery, Mount Sinai Hospital, 600 University Avenue, Suite 401, Toronto, ON, M5G 1X5, Canada.

Mohammed Mamdani (M)

Department of Otolaryngology - Head & Neck Surgery, Mount Sinai Hospital, 600 University Avenue, Suite 401, Toronto, ON, M5G 1X5, Canada.

Allan Vescan (A)

Department of Otolaryngology - Head & Neck Surgery, Mount Sinai Hospital, 600 University Avenue, Suite 401, Toronto, ON, M5G 1X5, Canada.

Christina MacMillan (C)

Department of Laboratory Medicine & Pathobiology - Anatomic Pathology, Mount Sinai Hospital, Toronto, ON, Canada.

Joel Davies (J)

Department of Otolaryngology - Head & Neck Surgery, Mount Sinai Hospital, 600 University Avenue, Suite 401, Toronto, ON, M5G 1X5, Canada. joel.davies@sinaihealth.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH